Seller record · Telehealth service
The Aesthetic Concierge
Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The pricing page refers only to a trusted FDA 503A compounding pharmacy in the United States. 2 more criteria also fail; see the table below.
At a glance
The Aesthetic ConciergeTelehealth service
- Price
- Compounded semaglutide $414 every 5 weeks on sale, regular $479, after a $579 kick-off appointment
- Sells
- compounded semaglutide injections, compounded tirzepatide injections, and 6 more
- FDA letters
- None on file
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A Charlotte, North Carolina concierge weight loss practice led by a physician medical director, offering compounded semaglutide and tirzepatide, microdosing and maintenance plans by virtual visit, plus a support program for patients on insurance-covered brand-name GLP-1s and add-on injections.
Operating entity No legal entity name appears in the footer, on the contact page or in the privacy policy, which name the business only as The Aesthetic Concierge, and no terms page is linked.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | The Aesthetic Concierge's website; The Aesthetic Concierge's experts page |
| S2 | Prescription gating | PASS | The Aesthetic Concierge's weight wellness pricing page; The Aesthetic Concierge's website |
| S3 | Pharmacy identification | FAIL | The Aesthetic Concierge's weight wellness pricing page |
| S4 | Compounding disclosure | FAIL | The Aesthetic Concierge's weight wellness pricing page; The Aesthetic Concierge's FAQ |
| S5 | Analytical documentation | FAIL | The Aesthetic Concierge's weight wellness pricing page; The Aesthetic Concierge's FAQ; The Aesthetic Concierge's GLP-1 microdosing page |
| S6 | Business address | PASS | The Aesthetic Concierge's contact page |
| S7 | Price disclosure | PASS | The Aesthetic Concierge's weight wellness pricing page; The Aesthetic Concierge's FAQ |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide injections, compounded tirzepatide injections, oral semaglutide, GLP-1 microdosing, NAD+ injection, GHK-Cu facial serum and scalp solution, B12, lipotropic and glutathione injections, hormone therapy.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells NAD+Who sells glutathioneWho sells GHK-Cu
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.